Table 1.
Results of EGFR mutation diagnostic tests | In house NGS (Amplicon Seq) | ||||||||
---|---|---|---|---|---|---|---|---|---|
Cobas® | Scorpion-ARMS | ||||||||
JFCR-226 | JFCR-065 | PC9 | A431 | JFCR-226 | JFCR-065 | PC9 | A431 | JFCR-226 | |
EGFR exon18 G719X | × | × | × | × | × | × | × | × | EGFR: c2239_2240TT > CC (p.L747P) |
EGFR exon19 deletions | 〇 | 〇 | 〇 | × | 〇 | 〇 | 〇 | × | |
EGFR exon20 S768I | × | × | × | × | × | × | × | × | |
EGFR exon20 Insertions | × | × | × | × | × | × | × | × | |
EGFR exon20 T790M | × | × | × | × | × | × | × | × | |
EGFR exon21 L858R | × | × | × | × | × | × | × | × | |
EGFR exon21 L861Q | × | × | × | × | × | × | × | × |
〇; positive, ×; negative.
PC9; EGFR exon19 deletion positive NSCLC cell line.
JFCR-065; EGFR exon19 deletion positive NSCLC cell line.
A431; EGFR wild (EGFR gene amplified).
(a) Comparison of LCC226, LCC065 (patient-derived cells expressing EGFR 19 deletions), PC9 (cells expressing EGFR 19 deletions), and A431 (human squamous carcinoma cells harboring wildtype EGFR gene amplification) by Cobas® and Scorpion-ARMS® EGFR gene mutation analysis results and LCC226 NGS analysis results.